跳至主要内容
临床试验/CTRI/2025/07/092024
CTRI/2025/07/092024尚未招募2/3 期

Effect of Gokshuradi kashaya pana and Gokshuradi ruksha vasti in Diabetic Nephropathy

Dr Haripriya Vijayan1 个研究点 分布在 1 个国家目标入组 23 人开始时间: 2025年8月18日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
23
试验地点
1
主要终点
Changes in Albumin Creatinine ratio

研究概览

简要总结

This is an interventional study in a single group of participants where Gokshuradi kashaya is given internally for a period of 30 days and Gokshuradi ruksha vasti for 7 days in 1 2 and 3 stages of Diabetic Nephropathy. Ayurvedicinterventions targeting the reversal of microalbuminuria and prevention of progression to overt Nephropathy and which causing reversal of the structural damage of nephrons is needed in this condition. Gokshuradi kashaya mentioned in Sahasrayoga sopha chikitsa is selected as the drug of choice for the study. Effect is assessed by Albumin creatinine ratio and eGFR. Assessment will be done on 0th and 31st day.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
35.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Diagnosed subjects of type 2 Diabetes Mellitus with Diabetic nephropathy With age group between 35-70 yrs With microalbumin ranges between 20 -200 microgram/min S.Creatinine level within 5 Who are fit for Vasthikarma Who are willing to participate and able to give consent.

排除标准

  • HbA1C greater than 9 Diabetic Nephropathy Stage 4 and 5 Pregnancy and lactation Known case of uncontrolled other systemic illness With persistent UTI Taking ACE inhibitors and ARBs Subjects with other severe debilitating diseases.

结局指标

主要结局

Changes in Albumin Creatinine ratio

时间窗: 0th and 31st day

次要结局

  • Changes in eGFR(0th and 30th day)

研究者

发起方
Dr Haripriya Vijayan
申办方类型
Other [PG Scholar Govt Ayurveda College Tripunithura ]
责任方
Principal Investigator
主要研究者

Dr Haripriya Vijayan

Govt Ayurveda College

研究点 (1)

Loading locations...

相似试验